USPTO serial 85196161
Serial No. 85196161
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 8, 2013
- Examiner
- CARLYLE, SHAUNIA P
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with Serial No. 85196161?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Minato-ku, Tokyo, JP
Minato-ku, Tokyo, JP
Minato-ku, Tokyo, JP
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Doreen L. Costa
DOREEN L. COSTA BAKER BOTTS LLP30 ROCKEFELLER PLZ 44TH FLNEW YORK, NY 10112-4498UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical powders and emulsifiers for use in the manufacture of health foods and supplements; chemical powders and emulsifiers for use in the manufacture of cosmetics; chemicals for use in the manufacture of pharmaceutical preparations; chemical preparations for general industrial manufacturing | SECTION 8 - CANCELLED | — |
| 003 | Cosmetics; non-medicated toiletries; soaps; detergents for household use; dentifrices, fragrances and perfumery, incenses; false nails; false eyelashes; anti-static preparations for household purposes; de-greasing preparations for household purposes; rust removing preparations; stain removing preparations; fabric softeners for laundry use; laundry bleaches | SECTION 8 - CANCELLED | — |
| 005 | Pharmaceutical preparations, namely, central nervous system agents, peripheral nervous system agents, sensory organ agents, miscellaneous nervous system and sensory organ agents, cardiovascular agents, respiratory organ agents, digestive organ agents, hormones, urogenital and anal organ agents, epidermides, dental preparations, miscellaneous organ agents, vitamins, nutrients, tonics, blood and body fluid agents, dialysis agents, miscellaneous metabolism agents, cellular function activating agents, antineoplastics, radioactive drugs, allergic agents, miscellaneous cellular function agents, crude drugs, antibiotics, chemotherapeutics, biological preparations, parasitics (systemic), pathogenic organism agents, dispensing medicines, intracorporeal diagnostic agents for medical purposes, extracorporeal diagnostic agents for medical purposes, prescription alkaloidal narcotics, prescription non-alkaloidal narcotics, and traditional Chinese medicines, public health agents and non-main therapeutic purpose agents for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, circulatory system, respiratory system, digestive system, endocrine system, urogenital and anal organs, epidermis, mouth, blood system, liver, kidney, metabolic system and immune system; sanitary preparations for medical use; oiled paper for medical purposes; drug delivery agents in the form of pharmaceutical wafers and gelatin-starch films for providing controlled release of the active ingredients for a wide variety of pharmaceuticals; gauze; empty capsules for pharmaceuticals; eye patches for medical purposes; ear bandages for dressings; sanitary pads; menstruation tampons; sanitary napkins; sanitary panties; cotton for medical purposes; bandages for skin wounds, medical plasters, medical dressings; medical dressing in liquid form, medical dressings containing collodion for pharmaceutical purposes; breast-nursing pads; dental composite materials; incontinence diapers; dietetic lactic sugar for medical use; powdered milk for infants; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing astaxanthin as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing ceramide as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing vitamin E as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing lycopene as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing vitamin C as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing selenium yeast as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing zinc yeast as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing concentrated salacia extract powder as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing onion integument extract as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing chitosan as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing apple polyphenol as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing tea catechin as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing chromium yeast as a principal ingredient | SECTION 8 - CANCELLED | — |
| 035 | Retail and wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail and wholesale store services for cosmetics and toiletries; retail and wholesale store services for processed foods; advertising for others via websites on the Internet; providing businesses information through websites on the Internet; providing consumer products information through websites on the Internet; retail and wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies through websites on the Internet; retail and wholesale store services for cosmetics and toiletries through websites on the Internet; retail and wholesale store services for processed foods through websites on the Internet | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by FUJIFILM Corporation
- Other trademarks owned by FUJIFILM Corporation
- Other trademarks owned by FUJIFILM Corporation
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 035
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 9, 2019 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 8, 2018 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jan 8, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 5, 2012 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Dec 5, 2012 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 3, 2012 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Dec 3, 2012 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Nov 27, 2012 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 2, 2012 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 2, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 12, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 28, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 22, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 1, 2012 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 31, 2012 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 31, 2012 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 31, 2012 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 9, 2012 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jun 25, 2012 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jun 12, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 12, 2012 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Jun 12, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 25, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 25, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 19, 2012 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 19, 2012 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Apr 19, 2012 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Apr 19, 2012 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Oct 19, 2011 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 19, 2011 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 19, 2011 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 27, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 27, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 15, 2011 | ALIE | ASSIGNED TO LIE | — |
| Sep 13, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 14, 2011 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 14, 2011 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 14, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 10, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 17, 2010 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Dec 16, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 16, 2010 | NWAP | NEW APPLICATION ENTERED | — |